Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Cited by (432)

Items 101–200 of 432

1. Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli
   María Ruiz-Ruigómez, Jose María Aguado · 2021 · Current Opinion in Infectious Diseases
2. Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients
   Hannah N. Imlay, Brad J. Spellberg · 2022 · Transplant Infectious Disease
3. Evaluating antimicrobial duration for Gram‐negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation
   Nischal Ranganath, Zachary A. Yetmar, A. McCandless, Christina Grace Rivera, Brian D. Lahr, Aaron Joseph Tande, Aditya Shah · 2023 · Transplant Infectious Disease
4. The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
   Carmen Prinsloo, Simon Smith, Matthew G. Law, Josh Hanson · 2023 · Tropical Medicine and Infectious Disease
5. Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative review
   Emily Gibson McDonald, Connor J. Prosty, Ryan Hanula, Émilie Bortolussi‐Courval, Arthur M. Albuquerque, Steven Y. C. Tong, Fergus Hamilton, Todd Campbell Lee · 2022 · Clinical Microbiology and Infection
6. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
   Nobuaki Shime, Taka‐aki Nakada, Tomoaki Yatabe, Kazuma Yamakawa, Yoshitaka Aoki, Shigeaki Inoue, Toshiaki Iba, Hiroshi Ogura, Yusuke Kawai, Atsushi Kawaguchi et al. · 2025 · Acute Medicine & Surgery
7. Clinical and microbiologic features of Achromobacter species: a 10-year, multicenter experience
   David R. Bayless, Mitchell G. Dumais, Jack McHugh, Nischal Ranganath, Madiha Fida, Supavit Chesdachai, Omar Abu Saleh · 2025 · Journal of Clinical Microbiology
8. Effectiveness of oral antibiotics for definitive therapy of non-Staphylococcal Gram-positive bacterial bloodstream infections
   Nicholas J. Quinn, Jamielynn C. Sebaaly, Bianka A. Patel, David A. Weinrib, William Edward Anderson, Danya Roshdy · 2019 · Therapeutic Advances in Infectious Disease
9. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia
   Olga Rodríguez-Núñez, Adrián Sousa, María Teresa Pérez-Rodríguez, Lucía Martínez-Lamas, Rebeca Longueira Suárez, C. Taboada Martínez, C. Portela Pino, F Vasallo Vidal, Antonio Pérez‐Landeiro, M. Crespo Casal · 2021 · Medicine
10. The time is now: antimicrobial stewardship in solid organ transplantation
    Jonathan M. Hand · 2021 · Current Opinion in Organ Transplantation
11. Common Dermatologic Disorders in Down Syndrome: Systematic Review
    Megan Lam, Justin D. Lu, Levi Elhadad, Cathryn J. Sibbald, Raed O. Alhusayen · 2022 · JMIR Dermatology
12. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
    Jesús Sojo-Dorado, Inmaculada López-Hernández, Alicia Hernández‐Torres, Pilar Retamar, Esperanza Merino, Laura Escolà‐Vergé, Elena Bereciartúa, Elisa García‐Vázquez, Vicente Pintado, Lucía Boix-Palop et al. · 2023 · Journal of Antimicrobial Chemotherapy
13. Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source
    Sameer Alzaidi, John J. Veillette, Stephanie Shealy May, Jared A Olson, Katarina Jackson, C. Dustin Waters, Allison M. Butler, Mary Hutton, Whitney R. Buckel, Brandon J. Webb · 2023 · Open Forum Infectious Diseases
14. Evaluation of OPAT in the Age of Antimicrobial Stewardship
    Monica V. Golik Mahoney, Keenan Levy Ryan, Bryan T. Alexander · 2020 · Current treatment options in infectious diseases/Current treatment options in infectious disease
15. Short‐course versus long‐course antibiotic treatment in patients with uncomplicated gram‐negative bacteremia: A systematic review and meta‐analysis
    Xiaoming Li, Chao Liu, Zhi Mao, Qinglin Li, Shuang Qi, Feihu Zhou · 2020 · Journal of Clinical Pharmacy and Therapeutics
16. Recommendations for antibiotic selection for severe nosocomial infections
    Josep Mensa, José Barberán, Ricard Ferrer, Marcío Borges-Sa, Pedro Rascado Sedes, Emilio Maseda, Antonio Oliver, Francesc Marco, Ramon Adàlia, Gerardo Aguilar et al. · 2021 · Revista Española de Quimioterapia
17. Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
    Sarah Singer, Lauren E. Kolodziej, Scott T. Micek, Marin H. Kollef · 2025 · Antibiotics
18. Expanding antimicrobial stewardship strategies for the NICU: Management of surgical site infections, perioperative prophylaxis, and culture negative sepsis
    Philip Zachariah, Lisa M. Saiman · 2020 · Seminars in Perinatology
19. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
    Tanya Babich, Pontus Nauclér, John Karlsson Valik, Christian G. Giske, Natividad Benito, Ruben Cardona, Alba Rivera, Céline Pulcini, Manal Abdel Fattah, Justine Haquin et al. · 2022 · Infectious Diseases and Therapy
20. Machine learning and synthetic outcome estimation for individualised antimicrobial cessation
    W. Bolton, Timothy M. Rawson, Bernard Hernandez, Richard C. Wilson, David Benjamin Antcliffe, Pantelis Georgiou, Alison Helen Holmes · 2022 · Frontiers in Digital Health
21. Can precision antibiotic prescribing help prevent the spread of carbapenem-resistant organisms in the hospital setting?
    Vasin Vasikasin, Timothy M. Rawson, Alison Helen Holmes, Jonathan A. Otter · 2023 · JAC-Antimicrobial Resistance
22. Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia
    Amber Bradley Clemmons, Henry Nolan Young, Christopher M. Bland, Brittany Jackson, Miki Hayashi, Chelsie Folsom, Daniel B. Chastain · 2021 · Diagnostic Microbiology and Infectious Disease
23. Short vs. long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials
    Itay Zahavi, Digbijay Kunwar, Judit Olchowski, Hagar Dallasheh, Mical Paul · 2025 · Clinical Microbiology and Infection
24. Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections
    Joshua T. Thaden, Pranita D. Tamma, Qing Pan, Yohei Doi, Nick Daneman · 2022 · JAC-Antimicrobial Resistance
25. Comparison between Short Therapy and Standard Therapy in Pediatric Patients Hospitalized with Urinary Tract Infection: A Single Center Retrospective Analysis
    Danilo Buonsenso, Giorgio Sodero, Francesco Mariani, Ilaria Lazzareschi, Francesco Proli, Giuseppe Zampino, Luca Pierantoni, Piero Valentini, Claudia Rendeli · 2022 · Children
26. Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study
    Caitlin L Soto, Alice Jenh Hsu, Jae Hyoung Lee, Kathryn Dzintars, Rebecca Choudhury, Timothy C Jenkins, Erin K McCreary, Katelyn S. Quartuccio, Erica J. Stohs, Matty Zimmerman et al. · 2023 · Clinical Infectious Diseases
27. State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
    Arsheena Yassin, Mariya Huralska, Jason M. Pogue, Deepali Dixit, Robert Grant Sawyer, Keith S. Kaye · 2023 · Clinical Infectious Diseases
28. Antibiotic treatment of common infections: more evidence to support shorter durations
    Benjamin J. Smith, George Heriot, Kirsty L. Buising · 2020 · Current Opinion in Infectious Diseases
29. The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae
    Elena Carrara, Michela Conti, Marianna Meschiari, Cristina Mussini · 2020 · Journal of Antimicrobial Chemotherapy
30. Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies
    David L. Paterson, Masahiro Kinoshita, Takamichi Baba, ROGER M. ECHOLS, Simon Portsmouth · 2022 · Infectious Diseases and Therapy
31. An Antimicrobial Treatment Assessment of Serratia marcescens Bacteremia and Endocarditis
    Douglas Slain, Catessa A Howard, Clinton Garret Cooper · 2022 · Frontiers in Antibiotics
32. Oral β-lactams vs fluoroquinolones and trimethoprim/sulfamethoxazole for step-down therapy forEscherichia coli,Proteus mirabilis, andKlebsiella pneumoniaebacteremia
    Michael McAlister, Dusten T T Rose, F. Parker Hudson, Eimeira Padilla‐Tolentino, Theresa Jaso · 2022 · American Journal of Health-System Pharmacy
33. Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized Trial
    Alyssa B Christensen, Brent W. Footer, Tobias Pusch, Kim Heath, Maha Iqbal, Lian Wang, Gregory B Tallman, Cameron Cover, Jennifer Marfori, Brian Kendall et al. · 2022 · Open Forum Infectious Diseases
34. Drugs for Gram-Negative Bugs From 2010–2019: A Decade in Review
    Benjamin Pontefract, Hong T Ho, Alexandria Crain, Madan Kumar Kharel, S. Eric Nybo · 2020 · Open Forum Infectious Diseases
35. Are we enrolling the right patients? A scoping review of external validity and generalizability of clinical trials in bloodstream infections
    Sean Wei Xiang Ong, Steven Y. C. Tong, Nick Daneman · 2023 · Clinical Microbiology and Infection
36. When to Stop Antibiotics in the Critically Ill?
    Nathan D. Nielsen, James T. Dean, Elizabeth A. Shald, Andrew Conway Morris, Pedro Manuel Sarmento Rodrigues Póvoa, Jeroen A. Schouten, Nicholas F. Parchim · 2024 · Antibiotics
37. Identifying targets for antibiotic stewardship interventions through analysis of the antibiotic prescribing process in hospitals - a multicentre observational cohort study
    Jannicke Slettli Wathne, Brita Skodvin, Esmita Charani, Stig Harthug, Hege Salvesen Blix, Roy M. Nilsen, Lars Kåre Selland Kleppe, Marta Vukovic, Ingrid Smith · 2020 · Antimicrobial Resistance and Infection Control
38. Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial
    Hugh L. Wright, Patrick N. A. Harris, Mark D. Chatfield, David Chien Lye, Andrew Henderson, Tiffany Harris‐Brown, Anna Donaldson, David L. Paterson · 2021 · Trials
39. Effectiveness of Shorter Versus Longer Durations of Therapy for Common Inpatient Infections Associated With Bacteremia: A Multicenter, Propensity-Weighted Cohort Study
    Leila S Hojat, Mary T. Bessesen, Misha Huang, Margaret Reid, Bryan C. Knepper, Matthew A. Miller, Katherine C Shihadeh, Randolph V. Fugit, Timothy C Jenkins · 2019 · Clinical Infectious Diseases
40. Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?
    Haein Kim, Hyeonji Seo, Hyemin Chung, Sung Hee Park, Heungsup Sung, Mi‐Na Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Sung‐Han Kim et al. · 2022 · Infection
41. Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice
    Stefano Di Bella, Bojana Beovič, Massimiliano Fabbiani, Michael Valentini, Roberto Luzzati · 2020 · Antibiotics
42. Antimicrobial Stewardship in Immunocompromised Patients
    Jonathan M. Hand, Hannah N. Imlay · 2023 · Infectious Disease Clinics of North America
43. An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study
    Chihiro Shiraishi, Hideo Kato, Toru Ogura, Takuya Iwamoto · 2024 · Scientific Reports
44. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database
    Lena Gajdos, Niccolò Buetti, Alexis Tabah, Stéphane Ruckly, Murat Akova, Frederik Sjöval, Kostoula Arvaniti, Jan J. De Waele, Hendrik Bracht, François Barbier et al. · 2025 · Intensive Care Medicine
45. Treatment of community-acquired bacterial brain abscess: a survey among infectious diseases specialists in France, Sweden, Australia, and Denmark
    Jacob Bodilsen, Pierre Tattevin, Steven Y. C. Tong, Pontus Nauclér, Henrik Ib Nielsen · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
46. Use of Fluoroquinolones or Sulfamethoxazole-Trimethoprim Compared to Β-Lactams for Oral Step-Down Therapy in Hospitalized Patients With Uncomplicated Enterobacterales Bacteremia
    Tyler Mack, Jon J. Hiles, Justin E Wrin, Armisha Desai · 2022 · Annals of Pharmacotherapy
47. Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
    Lauren Bjork, Teri L. Hopkins, Linda Yang, Chengwen Teng, Xavier Jones, José Cadena, Elizabeth A Walter, Christopher Raymond Frei · 2023 · International Journal of Medical Sciences
48. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia: A Propensity-Matched, Retrospective Cohort Study
    Evan Steere, Taryn A Eubank, Megan H. Cooper, Sage B. Greenlee, Ty C Drake · 2023 · Open Forum Infectious Diseases
49. Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial
    Ivor Russel Lee, Steven Y. C. Tong, Joshua Saul Davis, David L. Paterson, Sharifah Faridah Syed Omar, Kyong Ran Peck, Doo Ryeon Chung, Graham Cooke, Eshele Anak Libau, Nabilah Rahman et al. · 2022 · Trials
50. Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target
    Majdi N. Al‐Hasan · 2020 · Clinical Infectious Diseases
51. Optimal antibiotic use in the intensive care unit
    Micek, Scott T., Vazquez Guillamet, M. Cristina, Reynolds, Daniel, Matuszak, Sarah, Kolodziej, Lauren, Kollef, Marin H. · 2025 · Critical Care
52. Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections – Timing of Intravenous to Oral Antibiotics Transition for Complicated Urinary Tract Infections
    Barbara Wells Trautner, Nicolas W. Cortes-Penfield, Kalpana Gupta, Elizabeth B. Hirsch, Molly J. Horstman, Gregory J. Moran, Richard Colgan, John Charles O’Horo, Muhammad S Ashraf, S.J. Connolly et al. · 2025 · Clinical Infectious Diseases
53. Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)
    José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño‐Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez‐Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez et al. · 2022 · PLoS ONE
54. Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol
    Natalia Andrea Maldonado, Clara María Rosso-Fernández, Inés Portillo-Calderón, Irene Borreguero, Enriqueta Tristán‐Clavijo, Zaira Raquel Palacios-Baena, Elena Salamanca, Felipe Fernández-Cuenca, Marina de Cueto, Emilio Stolz et al. · 2023 · BMJ Open
55. Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making
    Fernando Ramasco Rueda, Rosa Méndez, Alejandro Suárez-de-la-Rica, Rafael González, Emilio Maseda · 2024 · Journal of Personalized Medicine
56. Antibiotic duration and route for treatment of adults with uncomplicated streptococcal bloodstream infections: a retrospective study in a large healthcare system
    Dana S. Clutter, Zahra Samiezade-Yazd, Jamila H. Champsi, Jeffrey M. Schapiro, Michael Jonah Silverberg · 2024 · Antimicrobial Agents and Chemotherapy
57. How to optimise duration of antibiotic treatment in patients with sepsis?
    Thomas P Hellyer, T Mantle, Ronan McMullan, Paul M Dark · 2020 · BMJ
58. Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda
    Maddalena Giannella, Pietro Malosso, Luigia Scudeller, Linda Bussini, Chiara Rebuffi, Milo Gatti, Michele Bartoletti, Stefano Ianniruberto, Livia Pancaldi, Renato Pascale et al. · 2021 · International Journal of Antimicrobial Agents
59. New evidence for managing Gram-negative bloodstream infections
    Amir Nutman, Chaitanya Tellapragada, Christian G. Giske, Dafna Yahav · 2021 · Current Opinion in Infectious Diseases
60. Antibiotic treatment of urinary tract infection and its impact on the gut microbiota
    Cees van Nieuwkoop · 2021 · The Lancet Infectious Diseases
61. Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: a retrospective comparison
    Amy E Spigelmyer, Catessa A Howard, Ilya Rybakov, Sheena Burwell, Douglas Slain · 2022 · International Journal of Clinical Pharmacy
62. A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards
    on behalf of the Canadian Critical Care Trials Group, Nick Daneman, Asgar H. Rishu, Ruxandra L Pinto, Yaseen M. Arabi, Emilie P. Belley‐Côté, Robert Cirone, Mark Downing, Deborah J. Cook, Richard Hall et al. · 2020 · Trials
63. Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
    Flaminia Olearo, Ilona Kronig, Stavroula Masouridi‐Levrat, Yves Chalandon, Nina Khanna, Jakob Robert Passweg, Michael Medinger, Nicolas Johannes Mueller, Urs Schanz, Christian van Delden et al. · 2020 · Open Forum Infectious Diseases
64. Our Most Important Discovery: The Question
    Scott R. Evans · 2021 · Statistics in Biopharmaceutical Research
65. Surgical Infection Society: Chest Wall Injury Society Recommendations for Antibiotic Use during Surgical Stabilization of Traumatic Rib or Sternal Fractures to Reduce Risk of Implant Infection
    Joseph Derek Forrester, Marko Bukur, Justin E. Dvorak, Bradley T. Faliks, David I. Hindin, Susan Kartiko, Tareq Kheirbek, Leo Y.-C. Lin, Morgan Manasa, Thomas J. Martin et al. · 2022 · Surgical Infections
66. Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure
    Titawadee Pradubkham, Gompol Suwanpimolkul, Alan Edward Gross, Chotirat Nakaranurack · 2022 · PLoS ONE
67. Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study
    Jorge Alba Fernandez, José Luís del Pozo, José Leiva, Mirian Fernández-Alonso, Irene Aquerreta, Azucena Aldaz, Andrés Blanco-Di Matteo, José Ramón Yuste · 2022 · Antibiotics
68. Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective
    Πέτρος Ιωάννου, Stamatis Karakonstantis, Jeroen A. Schouten, Tomislav Kostyanev, Esmita Charani, Vera Vlahović–Palčevski, Diamantis P. Kofteridis, Supported by the ESCMID Study Group for Antimicrobial Stewardship – ESGAP · 2022 · Transplant Infectious Disease
69. Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment
    David T.P. Buis, Cornelis H. van Werkhoven, Michiel A. van Agtmael, Hannelore I. Bax, Marvin A. H. Berrevoets, MGJ de Boer, Marc J. M. Bonten, Judith Ekkina Bosmans, Judith Branger, Sabrine Douiyeb et al. · 2023 · BMJ Open
70. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors
    Majdi N. Al‐Hasan, Alyssa P. Gould, Chelsea Drennan, Olivia Hill, Julie Ann Justo, Joseph E. Kohn, Paul Brandon Bookstaver · 2019 · Journal of Global Antimicrobial Resistance
71. Short versus prolonged duration of therapy for Pseudomonas aeruginosa bacteraemia: a systematic review and meta-analysis
    Nischal Ranganath, Leslie C. Hassett, Omar Abu Saleh, Zachary A. Yetmar · 2024 · Journal of Hospital Infection
72. Management of Common Postoperative Infections in the Surgical Intensive Care Unit
    Staci T. Aubry, Lena M. Napolitano · 2022 · Infectious Disease Clinics of North America
73. Oral antibiotic step-down therapy for nonstaphylococcal gram-positive bloodstream infections
    Kelvin Gandhi, Magdalena Wrzesinski, Kristen L. Bunnell, Allison Gibble · 2023 · Diagnostic Microbiology and Infectious Disease
74. The Overton Window and a Less Dogmatic Approach to Antibiotics
    Daniel J. Morgan · 2019 · Clinical Infectious Diseases
75. Investigator-initiated Randomized Controlled Trials in Infectious Diseases: Better Value for Money for Registration Trials of New Antimicrobials
    Mical Paul, Stephan Harbarth, Angela Huttner, Guy Edward Thwaites, Ursula Theuretzbacher, Marc J. M. Bonten, Leonard Leibovici · 2020 · Clinical Infectious Diseases
76. Current opinion in management of septic shock due to Gram-negative bacteria
    Alexis Tabah, Niccolò Buetti, François Barbier, JF Timsit · 2021 · Current Opinion in Infectious Diseases
77. A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021
    Mandy Lau, Rhian Daniel, Kathryn Hughes, Mandy Wootton, Kerenza Hood, David Gillespie · 2022 · JAC-Antimicrobial Resistance
78. Successful Treatment of Pantoea agglomerans Bacteremia Using Oral Antibiotics
    Megan Penner, Brittany Romans, Lauren Tah, Brianna Argubright, Matthew Strohmeyer · 2022 · Case Reports in Infectious Diseases
79. Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections in Children: Translating Evidence From Adults Into Pediatric Practice
    Rebecca G Same, Alice Jenh Hsu, Pranita D. Tamma · 2019 · Journal of the Pediatric Infectious Diseases Society
80. Short-course antibiotic therapy: The next frontier in antimicrobial stewardship
    Donald C. Sheppard · 2022 · Canada Communicable Disease Report
81. Maternal Sepsis Review and Update
    Fadi B. Yahya, Amy L. Van Abel, Benjamin D Brakke, Raj Palraj, Linda M. Szymanski, Megan L. Chapman, Yvonne Butler Tobah, Nipunie Rajapakse, Laura Dinnes · 2025 · Mayo Clinic Proceedings
82. Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection
    Ouli Xie, Kathryn Cisera, Lucy Taylor, Carly M. Hughes, Benjamin A. Rogers · 2020 · Annals of Clinical Microbiology and Antimicrobials
83. Antimicrobial Stewardship on Patients with Neutropenia: A Narrative Review Commissioned by Microorganisms
    Joana Alves, Betânia Abreu, Pedro Palma, Emine Alp, Tarsila Vieceli, Jordi Rello · 2023 · Microorganisms
84. Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm
    Fabián Herrera, Diego Torres, Ana Laborde, Rosana Jordán, Lucas Tula, Noelia Mañez, María Laura Pereyra, Nadia Suchowiercha, Lorena A. Berruezo, Carlota Gudiol et al. · 2024 · European Journal of Clinical Microbiology & Infectious Diseases
85. Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
    Stephanie C. Shealy, Matthew M. Brigmon, Julie Ann Justo, Paul Brandon Bookstaver, Joseph E. Kohn, Majdi N. Al‐Hasan · 2020 · Antibiotics
86. The Changing Landscape of Uncomplicated Gram‐Negative Bacteremia: A Narrative Review to Guide Inpatient Management
    Jeannie D. Chan, Chloe Bryson‐Cahn, Zahra Kassamali‐Escobar, John B. Lynch, Anneliese M. Schleyer · 2020 · Journal of Hospital Medicine
87. Short Course of Antibiotic Therapy for Gram-Negative Bacilli Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation: Less Is Possible
    Fabián Herrera, Diego Torres, Alberto A. Carena, Federico Nicola, A.N. Rearte, Elena Temporiti, Laura Jorge, Ricardo N. Valentini, Florencia Bues, Silvia Relloso et al. · 2023 · Microorganisms
88. Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic
    Christina Grace Rivera, Monica V. Golik Mahoney, Ryan W. Stevens, Omar Abu Saleh · 2020 · Open Forum Infectious Diseases
89. Opinion-Based Recommendations: Beware the Tyranny of Experts
    Brad J. Spellberg, Andrew F. Shorr · 2021 · Open Forum Infectious Diseases
90. Shortening Antibiotic Treatment Durations for Bacteremia
    Nick Daneman, Robert Fowler · 2018 · Clinical Infectious Diseases
91. Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia
    Mark P. Khurana, Jacob Liam Curran-Sebastian, Samir Bhatt, Gwenan M. Knight · 2024 · Scientific Reports
92. An Update on Recent Clinical Trial Data in Bloodstream Infection
    Adam G. Stewart, Peter Simos, Pirathaban Sivabalan, Laura Escolà‐Vergé, Katherine Garnham, Burcu Isler · 2024 · Antibiotics
93. Shorter versus longer-duration antibiotic treatments for immunocompetent patients with bloodstream infections: a systematic review and meta-analysis
    Ming Liu, Ya Gao, Zheng Li, Zhifan Li, Liang Yao, Jianguo Xu, Qingyong Zheng, Ping Zeng, Jinhui Tian · 2025 · EClinicalMedicine
94. Antibiotic-sparing strategies for multidrug-resistant organism (MDRO) infections
    Shuai Geng, Qing Tang, Ning Shi · 2025 · Frontiers in Pharmacology
95. The Role of Intravenous Fosfomycin: Finding Our Way Out of Dante’s Forest Dark
    Pranita D. Tamma, Robert A. Bonomo, Usha Stiefel · 2022 · JAMA Network Open
96. Follow-up blood cultures in Gram-negative bacteremia: How do they impact outcomes?
    Azza Elamin, Faisal Khan, Rajasekhar Jagarlamudi · 2022 · Journal of Community Hospital Internal Medicine Perspectives
97. Challenging management dogma where evidence is non-existent, weak, or outdated: part II
    Daniel A. Hofmaenner, Mervyn Singer · 2024 · Intensive Care Medicine
98. Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial
    Beatriz Arns, André C. Kalil, Guilherme Geraldo Lovato Sorio, Emerson Boschi, Ana Carolina Peçanha Antônio, Juliana Peçanha Antonio, Daniella Cunha Birriel, Daniel Haase Lanziotti, Frederico da Cunha Abbott, Glécia Carla Rocha et al. · 2024 · Critical Care
99. Potential to reduce antibiotic use in secondary care: Single-centre process audit of prescription duration using NICE guidance for common infections
    Neil Powell, Jennie Stephens, Rory Rule, Ryan Phillips, Megan Morphew, Emma Garry, Natasha Askaroff, Daniel Hiley, Charlie Strachan, Myles Sheehan et al. · 2021 · Clinical Medicine
100. Ceftriaxone 1 g Versus 2 g Daily for the Treatment of Enterobacterales Bacteremia: A Retrospective Cohort Study
     Nadeem Baalbaki, Sharon S. Blum, Meredith B. Akerman, Diane Elizabeth Johnson · 2022 · Journal of Pharmacy Technology